Cargando…

T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients

BACKGROUND: Human immunodeficiency virus (HIV) antigens from transmitted strains of HIV would prove crucial in vaccine designing for prevention of HIV infection. Immune response generated by Vaccinia construct expressing the HIV-1 gag gene from transmitted Indian HIV-1 subtype C strain (Vgag) in BAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shete, Ashwini V, Thakar, Madhuri R, Tripathy, Srikanth P, Raut, CG, Chakrabarti, Sekhar, Paranjape, Ramesh S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162811/ https://www.ncbi.nlm.nih.gov/pubmed/21887056 http://dx.doi.org/10.4103/0974-777X.83530

Ejemplares similares

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
por: Suryawanshi, Poonam, et al.
Publicado: (2021)

Is cure of HIV infection in sight?
por: Shete, Ashwini, et al.
Publicado: (2013)

A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians
por: Shete, Ashwini, et al.
Publicado: (2010)

Duplicate analysis method: a cheaper alternative to commercial IQC materials in limited resource settings for monitoring CD4 testing
por: Shete, Ashwini, et al.
Publicado: (2015)

Immunodomination during Peripheral Vaccinia Virus Infection
por: Lin, Leon C. W., et al.
Publicado: (2013)

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein
por: Hicar, Mark D., et al.
Publicado: (2016)

The presence of prolines in the flanking region of an immunodominant HIV‐2 gag epitope influences the quality and quantity of the epitope generated
por: Jallow, Sabelle, et al.
Publicado: (2015)

P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study
por: Vingert, B, et al.
Publicado: (2009)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

Characterization of Novel HIV-1 Intersubtype CRF01_AE/C and A1/C Recombinants from India
por: Pandey, Sudhanshu Shekhar, et al.
Publicado: (2015)

Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice
por: Cellini, Silvia, et al.
Publicado: (2008)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

Association of V(H)4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein
por: Chukwuma, Valentine U., et al.
Publicado: (2015)

Conformational plasticity of the HIV-1 gp41 immunodominant region is recognized by multiple non-neutralizing antibodies
por: Cook, Jonathan D., et al.
Publicado: (2022)

Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication
por: Kulkarni, Archana Gopal, et al.
Publicado: (2014)

Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India
por: Antwal, Megha, et al.
Publicado: (2014)

Mortality in HIV infected individuals in Pune, India
por: Ghate, Manisha, et al.
Publicado: (2011)

Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals
por: Shete, Ashwini, et al.
Publicado: (2020)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
por: Saha, Ipsita, et al.
Publicado: (2021)

FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017)

Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein
por: Kulkarni, Archana, et al.
Publicado: (2017)

Immunodominance and viral ditness in Gag may contribute to differential viral control in HLA-B*7 supertype individuals acutely infected with HIV-1C
por: Gounder, K, et al.
Publicado: (2012)

Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects
por: Jiang, Fanming, et al.
Publicado: (2016)

Nedd4-Mediated Increase in HIV-1 Gag and Env Proteins and Immunity following DNA-Vaccination of BALB/c Mice
por: Lewis, Brad, et al.
Publicado: (2014)

Safety and Immunogenicity of DNA and MVA HIV-1 Subtype C Vaccine Prime-Boost Regimens: A Phase I Randomised Trial in HIV-Uninfected Indian Volunteers
por: Mehendale, Sanjay, et al.
Publicado: (2013)

Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
por: Bauer, A, et al.
Publicado: (2012)

Development of subtype specific RealTime PCR based growth competition assay for assessing the replication fitness of drug resistant viruses of Indian HIV-1 clade C
por: Hingankar, Nitin K, et al.
Publicado: (2014)

Structural Basis for Unusual TCR CDR3β Usage Against an Immunodominant HIV-1 Gag Protein Peptide Restricted to an HLA-B*81:01 Molecule
por: Liu, Yang, et al.
Publicado: (2022)

Evaluation of a Cost Effective In-House Method for HIV-1 Drug Resistance Genotyping Using Plasma Samples
por: Chaturbhuj, Devidas N., et al.
Publicado: (2014)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Induction of HIV-specific T-cell responses by gag
por: Van Gulck, Ellen, et al.
Publicado: (2006)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles
por: Meador, Lydia R., et al.
Publicado: (2017)

Recent HIV infection testing algorithms
por: Murugavel, K.G., et al.
Publicado: (2020)

Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants
por: Ogunshola, Funsho, et al.
Publicado: (2018)

Post-transcriptional control of HIV-1 Gag expression
por: Phalora, Prabhjeet, et al.
Publicado: (2013)

The Life-Cycle of the HIV-1 Gag–RNA Complex
por: Mailler, Elodie, et al.
Publicado: (2016)

Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity
por: Monde, Kazuaki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t3psi26jlatqqcahmra5evtfc9